Summary Bio-Rad AbD Serotec Ltd (Bio-Rad), a subsidiary of Bio-Rad Laboratories Inc is an antibody supplier that manufactures and markets antibodies and reagents. The company supplies catalog antibodies, kits and accessories. It offers antibodies in the divisions of innate immunity, veterinary, cell health products, cell biology, cancer research, stem cells, apoptosis and autophagy, and microbiology antibodies and antigens, among others. Bio-Rad also provides epitope tag and reporter proteins, cell proliferation reagents, isotype controls, antibody manufacturing tools, innate immunity antibodies, immunology antibodies, veterinary antibodies, cell health product, cell biology antibodies, cancer research antibodies, apoptosis and autophagy, blocking reagents for ELISA, buffers for cell permeabilization, isotyping kits and mycoplasma detection reagents, among others. The company operates in Austria, Germany, Netherlands, Switzerland, Canada, the US, the UK, and France. Bio-Rad is headquartered in Oxford, the UK. Bio-Rad AbD Serotec Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions,... Research Beam Model: Research Beam Product ID: 1915910 250 USD New
Bio-Rad AbD Serotec Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Bio-Rad AbD Serotec Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Company Profiles
  • Published On : July   2017
  • Pages : 19
  • Publisher : GlobalData
 
 
 
Summary

Bio-Rad AbD Serotec Ltd (Bio-Rad), a subsidiary of Bio-Rad Laboratories Inc is an antibody supplier that manufactures and markets antibodies and reagents. The company supplies catalog antibodies, kits and accessories. It offers antibodies in the divisions of innate immunity, veterinary, cell health products, cell biology, cancer research, stem cells, apoptosis and autophagy, and microbiology antibodies and antigens, among others. Bio-Rad also provides epitope tag and reporter proteins, cell proliferation reagents, isotype controls, antibody manufacturing tools, innate immunity antibodies, immunology antibodies, veterinary antibodies, cell health product, cell biology antibodies, cancer research antibodies, apoptosis and autophagy, blocking reagents for ELISA, buffers for cell permeabilization, isotyping kits and mycoplasma detection reagents, among others. The company operates in Austria, Germany, Netherlands, Switzerland, Canada, the US, the UK, and France. Bio-Rad is headquartered in Oxford, the UK.

Bio-Rad AbD Serotec Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Bio-Rad AbD Serotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bio-Rad AbD Serotec Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bio-Rad AbD Serotec Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bio-Rad AbD Serotec Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Bio-Rad AbD Serotec Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Bio-Rad AbD Serotec Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Bio-Rad AbD Serotec Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
AbD Serotec Enters Into Licensing Agreement With DiaSorin For HuCAL Antibodies 11
AbD Serotec Enters Into Licensing Agreement With Proteomika 11
AbD Serotec Enters Into Research Agreement With Dana-Farber Cancer Institute 12
Licensing Agreements 13
AbD Serotec Amends Licensing Agreement With Merck 13
Acquisition 14
Bio-Rad Labs Completes Acquisition Of AbD Serotec From MorphoSys For US$70 Million 14
Bio-Rad AbD Serotec Ltd - Key Competitors 16
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19
List of Tables
Bio-Rad AbD Serotec Ltd, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Bio-Rad AbD Serotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bio-Rad AbD Serotec Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bio-Rad AbD Serotec Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bio-Rad AbD Serotec Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Bio-Rad AbD Serotec Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Bio-Rad AbD Serotec Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
AbD Serotec Enters Into Licensing Agreement With DiaSorin For HuCAL Antibodies 11
AbD Serotec Enters Into Licensing Agreement With Proteomika 11
AbD Serotec Enters Into Research Agreement With Dana-Farber Cancer Institute 12
AbD Serotec Amends Licensing Agreement With Merck 13
Bio-Rad Labs Completes Acquisition Of AbD Serotec From MorphoSys For US$70 Million 14
Bio-Rad AbD Serotec Ltd, Key Competitors 16
Bio-Rad AbD Serotec Ltd, Key Employees 17
Bio-Rad AbD Serotec Ltd, Other Locations 18List of Figures
Bio-Rad AbD Serotec Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Bio-Rad AbD Serotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Bio-Rad AbD Serotec Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Bio-Rad AbD Serotec Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Bio-Rad AbD Serotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bio-Rad AbD Serotec Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Bio-Rad AbD Serotec Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bio-Rad AbD Serotec Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Bio-Rad AbD Serotec Ltd, Medical Devices Deals, 2011 to YTD 2017 9
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter